A detailed history of Corundum Group, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Corundum Group, Inc. holds 924 shares of DHR stock, worth $244,592. This represents 0.09% of its overall portfolio holdings.

Number of Shares
924
Previous 917 0.76%
Holding current value
$244,592
Previous $228,000 0.88%
% of portfolio
0.09%
Previous 0.11%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$235.51 - $267.98 $1,648 - $1,875
7 Added 0.76%
924 $230,000
Q1 2024

Apr 15, 2024

SELL
$224.58 - $256.19 $15,945 - $18,189
-71 Reduced 7.19%
917 $228,000
Q4 2023

Jan 23, 2024

BUY
$185.1 - $233.13 $21,656 - $27,276
117 Added 13.43%
988 $228,000
Q3 2023

Oct 17, 2023

SELL
$233.08 - $265.59 $57,803 - $65,866
-248 Reduced 22.16%
871 $216,000
Q2 2023

Jul 21, 2023

BUY
$224.99 - $256.14 $1,124 - $1,280
5 Added 0.45%
1,119 $268,000
Q1 2023

Apr 24, 2023

SELL
$239.75 - $277.0 $212,898 - $245,976
-888 Reduced 44.36%
1,114 $280,000
Q4 2022

Jan 12, 2023

BUY
$241.42 - $282.29 $15,209 - $17,784
63 Added 3.25%
2,002 $531,000
Q3 2022

Oct 18, 2022

BUY
$247.06 - $1507.4 $30,388 - $185,410
123 Added 6.77%
1,939 $501,000
Q2 2022

Jul 25, 2022

BUY
$237.11 - $299.66 $37,463 - $47,346
158 Added 9.53%
1,816 $460,000
Q1 2022

May 02, 2022

BUY
$257.27 - $315.76 $426,553 - $523,530
1,658 New
1,658 $486,000
Q3 2021

Nov 02, 2021

SELL
$272.21 - $332.43 $244,988 - $299,187
-900 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$225.08 - $271.69 $54,919 - $66,292
-244 Reduced 21.33%
900 $242,000
Q1 2021

May 10, 2021

SELL
$212.38 - $245.9 $7,858 - $9,098
-37 Reduced 3.13%
1,144 $257,000
Q4 2020

Feb 03, 2021

BUY
$212.5 - $245.46 $2,975 - $3,436
14 Added 1.2%
1,181 $262,000
Q3 2020

Nov 12, 2020

BUY
$177.16 - $215.33 $206,745 - $251,290
1,167 New
1,167 $251,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $193B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Corundum Group, Inc. Portfolio

Follow Corundum Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corundum Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corundum Group, Inc. with notifications on news.